Zilver® PTX® V Clinical Study
Public ClinicalTrials.gov record NCT01901289. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Zilver® PTX® V Clinical Study is a post-market clinical trial required by the US FDA to provide continued evaluation of the safety and effectiveness of the Zilver PTX Drug-Eluting Peripheral Stent in treatment of narrowing of the femoropopliteal arteries.
Study identification
- NCT ID
- NCT01901289
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2013
- Primary completion
- Nov 17, 2016
- Completion
- Feb 14, 2021
- Last update posted
- Mar 1, 2022
2013 – 2021
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA Palo Alto Health Care System | Palo Alto | California | 94304 | — |
| Stanford University Medical School | Stanford | California | 94305 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| The Cardiac and Vascular Institute | Gainesville | Florida | 32605 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| First Coast Cardiovascular Institute | Jacksonville | Florida | 32216 | — |
| Alexian Brothers Medical Center | Elk Grove Village | Illinois | 60007 | — |
| Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| New York-Presbyterian/ Weill Cornell Medical Center | New York | New York | 10065 | — |
| OhioHealth Research Institute | Columbus | Ohio | 43214 | — |
| University of Toledo Medical Center | Toledo | Ohio | 43614 | — |
| Holy Spirit Hospital | Camp Hill | Pennsylvania | 17011 | — |
| South Carolina Heart Center | Columbia | South Carolina | 29204 | — |
| Greenville Hospital System | Greenville | South Carolina | 29615 | — |
| Holston Valley Hospital | Kingsport | Tennessee | 37660 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01901289, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2022 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01901289 live on ClinicalTrials.gov.